Bernadette Bouchon-Theisen

Title: Bernadette Bouchon-Theisen: Innovator in Meningococcal Research

Introduction

Bernadette Bouchon-Theisen is a prominent inventor based in Strasbourg, France. She has made significant contributions to the field of microbiology, particularly in the study of Neisseria meningitidis. With a total of 2 patents, her work has advanced our understanding of bacterial infections and potential treatments.

Latest Patents

Her latest patents include innovations related to transferrin receptor subunit proteins of Neisseria meningitidis. The first patent describes a DNA fragment that encodes a protein recognized by an antiserum against the transferrin receptor of specific strains, IM2394 and IM2169. This invention also outlines a process for producing the protein through recombinant methods. The second patent similarly focuses on a DNA fragment encoding the tbp1 and tbp2 subunits of the transferrin receptor, emphasizing their potential in vaccine development.

Career Highlights

Throughout her career, Bernadette has worked with notable organizations, including Pasteur Merieux Serums et Vaccins. Her research has been pivotal in developing strategies to combat meningococcal diseases, showcasing her dedication to public health.

Collaborations

Bernadette has collaborated with esteemed colleagues such as Anthony Bernard Schryvers and Eric Jacobs. These partnerships have enriched her research and contributed to the advancement of knowledge in her field.

Conclusion

Bernadette Bouchon-Theisen's innovative work in the realm of meningococcal research highlights her role as a key inventor in microbiology. Her patents reflect her commitment to improving health outcomes through scientific discovery.